LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company focused on treating iron deficiency anemia and developing novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today announced that Ricardo Zayas has been appointed Senior Vice President of Operations. Mr. Zayas brings over two decades of pharmaceutical operations and commercial manufacturing experience to the Company. In his new position with AMAG, Mr. Zayas will be responsible for leading the Company’s manufacturing, materials management, quality assurance, quality control, and supply chain functions and will report directly to Brian J.G. Pereira, MD, President and CEO.
